Ex-Genentech CEO joins Shire board of directors

Ireland-headquartered Shire (LSE: SHP) has announced the appointment of Ian Clark as a non-executive director of the company with effect from today (January 3).

Mr Clark served as chief executive and director of US biotech giant Genentech Inc (part of the Swiss Roche group) and head of North American commercial operations for Roche until December 31, 2016, having held several senior strategy, operations and commercially focused roles since joining Genentech in 2003. Prior to this Mr Clark held various senior operational, sales and marketing roles in other pharmaceutical and healthcare companies.

Susan Kilsby, Shire’s chairman, commented: “We are very pleased to announce Ian’s appointment at this important time; his in-depth knowledge of the biotechnology sector and breadth of operational experience stand to serve Shire well as we look forward to growing our business and addressing unmet patient needs world-wide.”